Bloomberg News

Prolor Poised for Highest Close Since December on Factor Success

February 15, 2012

Feb. 14 (Bloomberg) -- Prolor Biotech Inc. was headed for its highest close since December after it said its long-acting clotting factor may provide hemophilia patients with prolonged protecting from bleeding episodes.

Shares climbed 4.5 percent to 24.76 shekels at 3:42 p.m. in Tel Aviv, poised to close at the highest level since Dec. 26.

To contact the reporter on this story: Gwen Ackerman in Jerusalem at

To contact the editor responsible for this story: Claudia Maedler at

The Aging of Abercrombie & Fitch
blog comments powered by Disqus